AnJie Broad Law Firm
AnJie Broad Law Firm has responded to the rapid development of high-end manufacturing, AI, and biotechnology in China by increasingly handling private equity and venture capital transactions in these industries, representing a broad range of investment institutions and corporate clients. Shanghai-based Hans Cai leads the team and oversees a practice that is also well regarded in the fields of AI, e-commerce, ESG and sports. Ting Yao is another prominent figure, having represented numerous well-known US dollar funds, RMB funds, state-owned capital investors and industrial investors. Huan Chen has also established a solid reputation in this space, especially amongst significant regional players such as CICC and Legend Capital.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Chen Huan can give clear and feasible suggestions in a timely manner within a highly tense timetable, as well as the consequences of the suggestions not being accepted by the other party, so that we can quickly make judgments.’
‘AnJie Law Firm is a trustworthy partner. The lawyers of this law firm are skilled in business and can provide customers with one-stop service. They are very friendly to start-up companies like us and save us a lot of trouble. The law firm has low turnover of personnel, can accompany the growth of users for a long time, and provides various services such as intellectual property rights and trademark registration.’
‘One of the biggest characteristics of the AnJie team is that they have a better understanding of customer requirements, and can constantly adjust their team's capabilities and direction according to the track and stage of the customer's investment.’
‘Professionalism in M&A transactions, antitrust, etc.’
‘Ms. Yao Ting and her team have demonstrated full professionalism and due diligence in previous cooperation, and assisted us in successfully completing the transaction.’’
‘Anjie's team is very good at private equity and venture capital, and continues to improve the service process.’
Key clients
- 5Y Capital (formerly known as Morningside Venture Capital) (五源资本，原晨兴资本)
- ShuKun Technology (数坤科技)
- Source Code Capital
- Vitalbridge Capital
- Shunwei Capital
- Linear Capital
- Unity Capital
- GSR Ventures
- Eastern Bell Capital
- Cheng Heng Group
- Datafues Inc (aka. Datafuse Labs/Databend)
- Plum Ventures
- Lynk Pharmaceuticals Co., Ltd
- Zion Pharma (Cayman) Holdings Ltd
- CICC Capital
- Legend Capital
- Yunzhou Capital
- Goldenbrick Capital
- Runke Fund
- Guizhou Railway Investment Group
- 5Y Capital (五源资本)
- Long Hill Capital (长岭资本)
- Zhejiang SilkRoad Fund (浙江丝路基金)
- G7 Connect (G7物联)
- Bayland Capital (康君资本)
- Enlight Growth Partners
- CICC
- Legend Capital
- China Structural Reform and Strategy Private Equity Fund
- Beijing Haotang Technology Co., Ltd. (aka. Pet’em)
Work highlights
- Represented Zhongjin Qichen (Suzhou) Industry Equity Investment Fund Partnership (Limited Partnership), an equity investment fund managed by CICC Capital, in its investment into Xingfu Electronic Materials Co. Ltd.
- Represented Zhongjin Chuanyu, an equity investment fund managed by CICC Capital, in its investment into Zhejiang Jinyi Shengshi Bioengeneering Co. Ltd.
- Advised Zhongjin Qichen, an equity investment fund managed by CICC Capital, on its investment into Fujian Herui Gene Technologies Co. Ltd.
Practice head
The lawyer(s) leading their teams.
Hans Cai